ticlopidine has been researched along with Hakim Syndrome in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkeland, P | 1 |
| Lauritsen, J | 1 |
| Poulsen, FR | 1 |
1 other study available for ticlopidine and Hakim Syndrome
| Article | Year |
|---|---|
Aspirin is associated with an increased risk of subdural hematoma in normal-pressure hydrocephalus patients following shunt implantation.
Topics: Aged; Aged, 80 and over; Aspirin; Cerebrospinal Fluid Shunts; Clopidogrel; Female; Fibrinolytic Agen | 2015 |